Highlights•This consensus paper provides key recommendations on the management of
epithelioid hemangioendothelioma (EHE).•Recommendations followed a consensus …

Taxanes (paclitaxel and docetaxel) play an important role in the treatment of advanced
sarcomas. Albumin-bound paclitaxel (nab-paclitaxel) is a new kind of taxane and has many …

Epithelioid hemangioendothelioma: a nationwide study Epithelioid hemangioendothelioma
(EHE) is an ultrarare sarcoma whose natural history and treatment is not well defined. We …

Background In ultra-rare sarcomas (URS) the conduction of prospective, randomized trials is
challenging. Data from retrospective observational studies (ROS) may represent the best …

Focal liver lesions (FLLs) have become an increasingly common finding on abdominal
imaging, especially asymptomatic and incidental liver lesions. Gastroenterologists and …

Simple Summary Epithelioid haemangioendothelioma (EHE) is an ultra-rare malignant
vascular tumour with a prevalence of 1 per 1,000,000. It develops from endothelial cells …

Background Epithelioid hemangioendothelioma (EHE) is an ultra-rare, vascular sarcoma
with clinical presentation ranging from an indolent to an aggressive form. Over 50% of …

Epithelioid hemangioendothelioma (EHE) is a remarkably rare tumor arising from
endothelial cells that is classified as a vascular tumor in the WHO classification. The tumor is …

Introduction Despite extensive research undertaken in the past 20–30 years, the treatment
for soft tissue sarcoma (STS) has remained largely the same, with anthracycline-based …

Aim: Hemangioendotheliomas (HEs) are malignant vascular tumors with sparse descriptions
in literature owing to their rarity. Study design: Ours is a retrospective study among patients …